Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapy

Sun J, Zager JS, Eroglu Z

OncoTargets and Therapy 2018, 11:9081-9089

Published Date: 14 December 2018